Charles Laidi, Noomane Bouaziz, Emmanuel Haffen, Philippe Domenech, Edouard Duchesnay, Pauline Favre, Éric Fakra, Josselin Houenou, Anton Iftimovici, Antoine Lefrere, Mircea Polosan, Guillaume Sescousse, Anne Sauvaget, Renaud Jardri
{"title":"[Brain imaging and the first success of precision psychiatry].","authors":"Charles Laidi, Noomane Bouaziz, Emmanuel Haffen, Philippe Domenech, Edouard Duchesnay, Pauline Favre, Éric Fakra, Josselin Houenou, Anton Iftimovici, Antoine Lefrere, Mircea Polosan, Guillaume Sescousse, Anne Sauvaget, Renaud Jardri","doi":"10.1051/medsci/2025061","DOIUrl":null,"url":null,"abstract":"<p><p>Magnetic resonance imaging (MRI) can be used to investigate the neurobiological basis of psychiatric disorders such as schizophrenia, bipolar disorders, autism spectrum disorders and resistant depression. Although differences in cortical thickness between patients and controls have been well demonstrated, there is currently no valid MRI-based biomarker for psychiatric disorders. The challenge of precision psychiatry is to develop biomarkers, that are specific for a given pathology or clinical dimension, but also capable of predicting clinical evolution or response to treatment, to transform patient management. Functional magnetic resonance imaging could also be a promising tool for the individualized targeting of non-invasive neuromodulation in depression or resistant hallucinations, as well as for functional magnetic resonance imaging-based neurofeedback.</p>","PeriodicalId":18205,"journal":{"name":"M S-medecine Sciences","volume":"41 5","pages":"500-507"},"PeriodicalIF":0.4000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"M S-medecine Sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1051/medsci/2025061","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/26 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Magnetic resonance imaging (MRI) can be used to investigate the neurobiological basis of psychiatric disorders such as schizophrenia, bipolar disorders, autism spectrum disorders and resistant depression. Although differences in cortical thickness between patients and controls have been well demonstrated, there is currently no valid MRI-based biomarker for psychiatric disorders. The challenge of precision psychiatry is to develop biomarkers, that are specific for a given pathology or clinical dimension, but also capable of predicting clinical evolution or response to treatment, to transform patient management. Functional magnetic resonance imaging could also be a promising tool for the individualized targeting of non-invasive neuromodulation in depression or resistant hallucinations, as well as for functional magnetic resonance imaging-based neurofeedback.
期刊介绍：
m/s offers high-quality review articles in French, covering all areas of biomedical and health research, in a monthly magazine format (10 issues / year). m/s is read by the whole French-speaking community, in France but also in Belgium, Switzerland, Canada, Morocco, Algeria, Tunisia etc. m/s is not a primary publication, and thus will not consider unpublished data. Most articles are invited by the Editors, but spontaneous proposals are welcomed. Each issue combines news and views on the most recent scientific publications, as well as broadly accessible and updated review articles on a specific topic, and essays on science and society, history of science, public health, or reactions to published articles. Each year, m/s also publishes one or two thematic issues focused on a research topic of high interest. All review articles and essays are peer-reviewed.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
